Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
53286001000001110 | Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
53286101000001111 | Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Is a | Fluticasone propionate 50micrograms aqueous nasal spray | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Has active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Has manufactured dose form | Nasal dose form | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Has specific active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Has dispensed dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Is a | Fluticasone propionate 50micrograms/dose nasal spray | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) 150 dose | Has AMP | False | Fluticasone propionate 50micrograms/dose nasal spray (Sigma Pharmaceuticals Plc) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets